Most Read Articles
Roshini Claire Anthony, 16 Oct 2017

Treatment failure in osteoporosis remains a problem, even among patients who are treatment-adherent, according to a presentation at the recent meeting of the Asian Federation of Osteoporosis Societies (AFOS 2017), held in Kuala Lumpur, Malaysia. 

Elvira Manzano, 6 days ago
Bisphosphonates have proven antifracture efficacy and remain to be the cornerstone of osteoporosis treatment. However, a drug holiday is of particular importance with bisphosphonates due to some signals with long-term use of the drug, including rare incidence of atypical femoral fracture (AFF) and osteonecrosis of the jaw (ONJ), says a leading endocrinologist at AFOS 2017.
Yesterday
Drinking coffee, whether caffeinated or decaffeinated, is associated with a reduced risk of cardiovascular disease (CVD) and ischaemic heart disease (IHD) mortality in patients with a prior myocardial infarction (MI), according to a recent study.
2 days ago
Breast cancer patients have notably different microbiomes in the local breast tissue and urinary tract, a recent study reveals. Particularly, species in the Methylobacterium genus are reduced in the local breast tissue while the urinary tract is enriched in gram-positive bacteria.

HRT may preserve lung function in middle-aged women

Elvira Manzano
21 Sep 2017

Hormone replacement therapy (HRT) may help delay lung function decline in middle-aged women, according to results of a longitudinal analysis presented at ERS Congress 2017, demonstrating a possible role for female sex hormones in the preservation of lung function.

“Lung function peaks during the mid-20s, and from then on it will go down,” said lead investigator Dr Kai Triebner, a postdoctoral fellow at the University of Bergen in Bergen, Norway. “However, it is possible to identify which factors influence the decline – either by slowing it down, or accelerating it. One accelerating factor, for example, is the menopause. Therefore, a key question is whether HRT could, at least partly, counteract it.”

Triebner and his team sought to analyse spirometry data of 3,713 European women participating in the European Community Respiratory Health Survey who were followed for an average of 20 years (1990 to 2010). Women who took oral HRT for 2 years or longer (n=236) were matched with women who never took HRT (n=236) for age, height, age at menopause, smoking history, and baseline lung function. The women were nonmenopausal at baseline and postmenopausal at study end. Mean age in 2010 was 59 years. Lung function was assessed at baseline and 20 years later. [ERS 2017, abstract OA4420]

Women who had oral HRT for 2 years or longer performed better in lung function tests as assessed by forced vital capacity (FVC) and forced expiratory volume in one second (FEV1) compared with nonusers. Long-term use of HRT was associated with less lung function decline (-56.7 mL for FEV1 and -65.6 mL for FVC) compared with nonuse.  

The results may not be clinically significant in healthy women, said Triebner. “However, in women who are suffering from airway diseases, the decline in lung function may influence quality of life, as it could lead to an increase in shortness of breath, reduced work capacity, and fatigue.”

“To put these findings in context, if a woman smoked a pack of cigarettes a day for 3 years, the loss of FVC would correspond roughly in size to 46 mL,” he further elucidated.

Of note, physical activity and surgical menopause were not significantly associated with lung function decline. “However, in my personal opinion, physical exercise is still desirable.”

There have been safety concerns on the use of HRT. Debates are still ongoing hence, it may be too early to recommend this therapy in the lung-health setting. Trieber clarified that he is not advocating for HRT though and that their findings merely offer more information that can help women and their physicians in making the right treatment decisions. 

 

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 16 Oct 2017

Treatment failure in osteoporosis remains a problem, even among patients who are treatment-adherent, according to a presentation at the recent meeting of the Asian Federation of Osteoporosis Societies (AFOS 2017), held in Kuala Lumpur, Malaysia. 

Elvira Manzano, 6 days ago
Bisphosphonates have proven antifracture efficacy and remain to be the cornerstone of osteoporosis treatment. However, a drug holiday is of particular importance with bisphosphonates due to some signals with long-term use of the drug, including rare incidence of atypical femoral fracture (AFF) and osteonecrosis of the jaw (ONJ), says a leading endocrinologist at AFOS 2017.
Yesterday
Drinking coffee, whether caffeinated or decaffeinated, is associated with a reduced risk of cardiovascular disease (CVD) and ischaemic heart disease (IHD) mortality in patients with a prior myocardial infarction (MI), according to a recent study.
2 days ago
Breast cancer patients have notably different microbiomes in the local breast tissue and urinary tract, a recent study reveals. Particularly, species in the Methylobacterium genus are reduced in the local breast tissue while the urinary tract is enriched in gram-positive bacteria.